ELVN · Enliven Therapeutics, Inc.
$59.24
+0.32 (+0.54%)
At close · Aug 21
Market Cap
$4.32B
Shares
73.27M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-13 | 983,659 | 690,918 | 1,674,577 | 47.4% |
| 2026-07-06 | 1,931,599 | 1,056,141 | 2,987,740 | 54.3% |
| 2026-06-29 | 1,937,938 | 601,059 | 2,538,997 | 45.6% |
| 2026-06-22 | 4,439,976 | 3,380,605 | 7,820,581 | 46.3% |
| 2026-06-15 | 3,357,954 | 2,122,387 | 5,480,341 | 53.7% |
| 2026-06-08 | 6,503,812 | 1,763,777 | 8,267,589 | 54.4% |
| 2026-06-01 | 1,866,033 | 600,333 | 2,466,366 | 45.6% |
| 2026-05-25 | 827,969 | 181,757 | 1,009,726 | 47.9% |
| 2026-05-18 | 1,083,835 | 472,264 | 1,556,099 | 46.7% |
| 2026-05-11 | 1,448,024 | 535,193 | 1,983,217 | 48.2% |
| 2026-05-04 | 864,194 | 230,276 | 1,094,470 | 45.1% |
| 2026-04-27 | 1,076,799 | 265,745 | 1,342,544 | 43.2% |
| 2026-04-20 | 1,121,077 | 608,877 | 1,729,954 | 54.8% |
| 2026-04-13 | 2,161,084 | 695,145 | 2,856,229 | 50.6% |
| 2026-04-06 | 4,016,341 | 927,248 | 4,943,589 | 59.2% |
| 2026-03-30 | 2,171,325 | 701,979 | 2,873,304 | 49.1% |
| 2026-03-23 | 4,987,843 | 2,602,896 | 7,590,739 | 57.0% |
| 2026-03-16 | 1,798,824 | 3,990,856 | 5,789,680 | 68.7% |
| 2026-03-09 | 1,618,555 | 640,997 | 2,259,552 | 52.3% |
| 2026-03-02 | 1,363,166 | 364,768 | 1,727,934 | 48.0% |
| 2026-02-23 | 1,161,969 | 781,822 | 1,943,791 | 50.3% |
| 2026-02-16 | 996,973 | 217,424 | 1,214,397 | 44.1% |
| 2026-02-09 | 702,015 | 281,416 | 983,431 | 39.9% |
| 2026-02-02 | 1,472,638 | 1,068,919 | 2,541,557 | 52.5% |
| 2026-01-26 | 1,279,988 | 1,588,425 | 2,868,413 | 62.1% |
| 2026-01-19 | 1,843,131 | 371,099 | 2,214,230 | 52.0% |
| 2026-01-12 | 2,093,364 | 549,977 | 2,643,341 | 43.8% |
| 2026-01-05 | 5,750,479 | 3,095,013 | 8,845,492 | 52.0% |
| 2025-12-29 | 425,225 | 343,451 | 768,676 | 44.3% |
| 2025-12-22 | 906,959 | 265,429 | 1,172,388 | 52.2% |
| 2025-12-15 | 1,624,919 | 852,651 | 2,477,570 | 44.2% |
| 2025-12-08 | 2,217,255 | 840,457 | 3,057,712 | 55.3% |
| 2025-12-01 | 493,407 | 744,444 | 1,237,851 | 51.4% |
| 2025-11-24 | 368,400 | 822,360 | 1,190,760 | 51.1% |
| 2025-11-17 | 922,149 | 336,347 | 1,258,496 | 47.8% |
| 2025-11-10 | 835,149 | 286,184 | 1,121,333 | 44.6% |
| 2025-11-03 | 1,237,046 | 1,452,903 | 2,689,949 | 53.0% |
| 2025-10-27 | 941,963 | 151,510 | 1,093,473 | 51.2% |
| 2025-10-20 | 740,572 | 281,000 | 1,021,572 | 47.6% |
| 2025-10-13 | 843,358 | 291,830 | 1,135,188 | 50.4% |
| 2025-10-06 | 829,030 | 298,451 | 1,127,481 | 46.9% |
| 2025-09-29 | 417,141 | 348,426 | 765,567 | 46.5% |
| 2025-09-22 | 598,686 | 491,036 | 1,089,722 | 51.3% |
| 2025-09-15 | 698,027 | 2,093,928 | 2,791,955 | 51.8% |
| 2025-09-08 | 719,261 | 769,668 | 1,488,929 | 55.0% |
| 2025-09-01 | 302,597 | 355,951 | 658,548 | 44.5% |
| 2025-08-25 | 548,487 | 806,899 | 1,355,386 | 57.0% |
Showing 1–47 of 47 weeks
Key facts
CIK
1672619
CUSIP
29337E102
13F (30d)
203 filings
202 filers
Visit website
Investor relations